查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565658

传染病分子诊断市场，按测试类型、按应用、按产品和服务、按技术、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Infectious Diseases Molecular Diagnostics Market, By Test Type, By Application, By Products & Services, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年传染病分子诊断市场规模为370.9432亿美元，2024年至2032年复合年增长率为4.30%。

传染病分子诊断市场-市场动态

传染病发生率的上升推动了对传染病分子诊断市场的需求

包括病毒、细菌、真菌和寄生虫感染在内的传染病患者病率不断上升，大大增加了对有效诊断解决方案的需求。传染病日益成为全球健康问题，特别是随着新病原体的出现和先前控制的疾病的重新出现。根据美国国立卫生研究院 (NIH) 的数据，传染病仍然是全球发病和死亡的主要原因之一，全球每年有超过 5,200 万人 (33%) 死亡。世界上一半的人口仍面临新发和再发传染病的风险。最近的数据显示，全球估计有 1,400 万 5 岁以下儿童死亡，其中 70% 是由疫苗可预防的疾病造成的，其中 99% 发生在发展中国家。这推动了对先进分子诊断的需求，这种诊断可以在分子层面上快速、准确且灵敏地检测病原体。儘早识别传染源的能力可以及时干预，帮助疾病管理，降低传播率并改善患者的治疗结果。因此，传染病负担的增加是推动传染病分子诊断市场成长的关键因素。

传染病分子诊断市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.30% 左右的复合年增长率成长

根据测试类型细分，预计基于实验室的测试将在 2023 年显示最大的市场份额

按应用细分，2023年病毒感染为主导类型

根据产品和服务细分，试剂和试剂盒是 2023 年的主导类型

从技术细分来看，聚合酶炼式反应（PCR）是2023年的主导类型

根据最终用户细分，医院和诊断实验室是 2023 年的主导类型

按地区划分，亚太地区是 2023 年领先的收入来源

传染病分子诊断市场-細項分析：

全球传染病分子诊断市场根据测试类型、应用、产品和服务、技术、最终用户和地区进行细分。

市场根据技术分为七类：聚合酶炼式反应 (PCR)、等温核酸扩增技术 (INAAT)、次世代定序 (NGS)、DNA 微阵列、基于杂交的检测、CRISPR 诊断和其他 (Sanger)定序、多重PCR 等）。 PCR 可以高度准确地检测来自病原体的少量 DNA 或 RNA，使其成为诊断传染病的理想选择。这种精确度可以实现早期、准确的检测，这对于疾病管理和控制至关重要。即时 PCR (qPCR) 和数位 PCR (dPCR) 的发展增强了 PCR 的准确性、灵敏度和定量能力，使其成为传染病检测中更具吸引力的选择。

根据最终用途产业，市场分为五类：医院和诊断实验室、研究所、护理点测试设施、学术和医疗机构以及其他。医院收治了大量的传染病患者，需要先进的诊断工具来确保准确、及时的诊断。这推动了对分子诊断的需求，这对于在分子层面上以高特异性和敏感性检测病原体至关重要。高患者数量、技术进步、融入患者护理、研究参与和监管要求等因素相结合，使得医院在传染病分子诊断市场中占据了巨大的市场份额。

传染病分子诊断市场-地理洞察

在传染病流行率不断上升、医疗基础设施进步以及人们对早期疾病检测意识不断提高等因素的推动下，亚太地区传染病分子诊断市场正在显着增长。中国、印度、日本和韩国等国家是这一成长的主要贡献者，对快速诊断测试的需求激增，特别是在 COVID-19 等流行病爆发后。此外，政府的支持性政策、医疗保健创新资金的增加以及对精准医疗的日益关注正在促进分子诊断在整个地区的采用。

传染病分子诊断市场-竞争格局：

传染病分子诊断市场的特点是竞争激烈，全球主要参与者包括罗氏诊断公司、雅培实验室、赛默飞世尔科技公司、丹纳赫公司和豪洛捷公司。产品组合在市场上占据主导地位。例如，罗氏公司以其高度先进的聚合酶炼式反应 (PCR) 技术处于领先地位。 Abbott 和 Thermo Fisher 在快速检测和新一代定序 (NGS) 领域的产品也占有重要的市场份额。生物梅里埃、Qiagen 和 Cepheid（丹纳赫子公司）等中型企业也很突出，为传染病提供专门的分子诊断解决方案。新创公司和区域性公司正在利基领域进行创新，透过具有成本效益的快速诊断工具增加了竞争压力。随着公司旨在加强其产品组合和全球影响力，合作和策略收购是主要趋势。

最新进展：

2024年1月，Seegene宣布与微软合作，实现「没有疾病的世界」。这项策略合作开启了分子诊断领域的新篇章，旨在建立一个没有所有疾病和未来流行病的世界。

2020 年 2 月，Cepheid 和 Sherlock Biosciences 就利用 CRISPR 技术进行传染病和肿瘤学的 New GeneXpert 测试建立了合作。此次合作将重点放在传染病和肿瘤学的分子诊断测试，首先是专注于检测冠状病毒（SARS-CoV-2）的概念验证计画。

目录

第一章：传染病分子诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按测试类型分類的传染病分子诊断市场片段
    • 传染病分子诊断市场片段（依应用）
    • 按产品和服务分類的传染病分子诊断市场片段
    • 传染病分子诊断市场技术片段
    • 最终用户的传染病分子诊断市场片段
    • 按国家/地区分類的传染病分子诊断市场片段
    • 按地区分類的传染病分子诊断市场片段
  • 竞争洞察

第 3 章：传染病分子诊断主要市场趋势

  • 传染病分子诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 传染病分子诊断市场限制
    • 市场限制影响分析
  • 传染病分子诊断市场机会
  • 传染病分子诊断市场未来趋势

第 4 章：传染病分子诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：传染病分子诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：传染病分子诊断市场格局

  • 2023 年传染病分子诊断市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：传染病分子诊断市场 - 按测试类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 实验室测试
    • 即时分子诊断
    • 自检套件

第 8 章：传染病分子诊断市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 病毒感染
    • 细菌感染
    • 寄生虫感染
    • 霉菌感染
    • 其他（人畜共通感染等）

第 9 章：传染病分子诊断市场 - 按产品和服务

  • 概述
    • 按产品和服务分類的细分市场份额分析
    • 试剂和试剂盒
    • 仪器仪表
    • 软体与服务

第 10 章：传染病分子诊断市场 - 依技术分类

  • 概述
    • 按应用分類的细分市场占有率分析
    • 聚合酶炼式反应 (PCR)
      • 实时萤光定量PCR (qPCR)
      • 逆转录聚合酶连锁反应 (RT-PCR)
      • 其他的
    • 等温核酸扩增技术（INAAT）
    • 新一代定序 (NGS)
    • DNA微阵列
    • 基于杂交的测定
    • CRISPR 诊断
    • 其他（桑格定序、多重 PCR 等）

第 11 章：传染病分子诊断市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊断实验室
    • 研究所
    • 即时侦测设施
    • 学术及医疗机构
    • 其他的

第 12 章：传染病分子诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美传染病分子诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按产品和服务）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲传染病分子诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按产品和服务）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区传染病分子诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 按测试类型分類的亚太市场规模和预测
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按产品和服务）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲传染病分子诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按测试类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按产品和服务）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲传染病分子诊断主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按产品和服务）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第13章：主要供应商分析-传染病分子诊断产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Roche Diagnostics
    • BD (Becton, Dickinson and Company)
    • Thermo Fisher Scientific
    • Cepheid
    • QIAGEN
    • BioMerieux
    • GenMark Diagnostics
    • Luminex Corporation
    • MicroGen Diagnostics
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3817

REPORT HIGHLIGHT

Infectious Diseases Molecular Diagnostics Market size was valued at USD 37,094.32 Million in 2023, expanding at a CAGR of 4.30% from 2024 to 2032.

The Infectious Diseases Molecular Diagnostics market is a rapidly expanding sector driven by the increasing prevalence of infectious diseases, technological advancements in molecular diagnostics, and the need for precise, fast, and reliable diagnostic tools. Molecular diagnostics offer high sensitivity and specificity, allowing for early detection and monitoring of diseases caused by bacteria, viruses, fungi, and parasites. Key market drivers include the rise in healthcare spending, the growing burden of infectious diseases like COVID-19, HIV, and tuberculosis, and the demand for point-of-care testing solutions. As a result, companies are focusing on developing innovative diagnostic platforms, leading to enhanced market growth across regions, with North America and Europe being major contributors.

Infectious Diseases Molecular Diagnostics Market- Market Dynamics

Rising Prevalence of Infectious Diseases Drives the Need for the Infectious Diseases Molecular Diagnostics Market

The rising prevalence of infectious diseases, including viral, bacterial, fungal, and parasitic infections, has significantly increased the demand for effective diagnostic solutions. Infectious diseases pose a growing global health concern, particularly with the emergence of new pathogens and the re-emergence of previously controlled diseases. According to the National Institute of Health (NIH), Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million (33%) annual deaths worldwide. Half of the world's population remains at risk of emerging and re-emerging infectious diseases. The recent figures indicate an estimated 14 million global deaths in children less than 5 years of age, 70% of which resulted from vaccine-preventable diseases and 99% reported in developing countries. This has driven the need for advanced molecular diagnostics, which provide rapid, accurate, and sensitive detection of pathogens at a molecular level. The ability to identify infectious agents early on allows for timely intervention, aiding in disease management, reducing transmission rates, and improving patient outcomes. Consequently, the increasing burden of infectious diseases is a key factor propelling the growth of the infectious diseases molecular diagnostics market.

Infectious Diseases Molecular Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2024-2032)

Based on test type segmentation, Laboratory-based Tests were predicted to show maximum market share in the year 2023

Based on application segmentation, Viral Infections was the leading type in 2023

Based on Product & Service segmentation, Reagents & Kits was the leading type in 2023

Based on technology segmentation, Polymerase Chain Reaction (PCR) was the leading type in 2023

Based on end-user segmentation, Hospitals & Diagnostic Laboratories was the leading type in 2023

On the basis of region, Asia Pacific was the leading revenue generator in 2023

Infectious Diseases Molecular Diagnostics Market- Segmentation Analysis:

The Global Infectious Diseases Molecular Diagnostics Market is segmented on the basis of Test Type, Application, Product & Services, Technology, End User, and Region.

The market is divided into seven categories based on technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), DNA Microarray, Hybridization-based Assays, CRISPR Diagnostics, and Others (Sanger Sequencing, Multiplex PCR, etc.). PCR is highly accurate in detecting even small amounts of DNA or RNA from pathogens, making it ideal for diagnosing infectious diseases. This precision leads to early and accurate detection, essential for disease management and control. The development of real-time PCR (qPCR) and digital PCR (dPCR) has enhanced PCR's accuracy, sensitivity, and quantification capabilities, making it an even more attractive option in infectious disease testing.

The market is divided into five categories based on end use industry: Hospitals & Diagnostic Laboratories, Research Institutes, Point-of-Care Testing Facilities, Academic and Medical Institutions, and Others. Hospitals experience a high volume of patients with infectious diseases, necessitating advanced diagnostic tools to ensure accurate and timely diagnosis. This drives the demand for molecular diagnostics, which are crucial for detecting pathogens at a molecular level with high specificity and sensitivity. The combination of high patient volumes, technological advancements, integration into patient care, research involvement, and regulatory requirements contributes to the substantial market share held by hospitals in the Infectious Diseases Molecular Diagnostics market.

Infectious Diseases Molecular Diagnostics Market- Geographical Insights

The Asia-Pacific region is witnessing significant growth in the Infectious Diseases Molecular Diagnostics market, driven by factors such as the increasing prevalence of infectious diseases, advancements in healthcare infrastructure, and rising awareness about early disease detection. Countries like China, India, Japan, and South Korea are key contributors to this growth, with a surge in demand for rapid diagnostic tests, particularly in the wake of pandemics such as COVID-19. Additionally, supportive government policies, increased funding for healthcare innovation, and a growing focus on precision medicine are fostering the adoption of molecular diagnostics across the region.

Infectious Diseases Molecular Diagnostics Market- Competitive Landscape:

The Infectious Diseases Molecular Diagnostics market is characterized by a competitive landscape featuring key global players, including Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, and Hologic Inc. These companies dominate the market due to their strong portfolios of molecular diagnostic platforms, extensive distribution networks, and focus on research and development. Roche, for instance, leads with its highly advanced polymerase chain reaction (PCR) technology. Abbott and Thermo Fisher also hold significant market shares with their offerings in rapid testing and next-generation sequencing (NGS). Mid-sized players like bioMerieux, Qiagen, and Cepheid (a subsidiary of Danaher) are also prominent, providing specialized molecular diagnostic solutions for infectious diseases. Start-ups and regional companies are innovating in niche areas, adding competitive pressure with cost-effective and rapid diagnostic tools. Collaboration and strategic acquisitions are key trends as companies aim to strengthen their portfolios and global reach.

Recent Developments:

In Jan 2024, Seegene Announced the collaboration with Microsoft to Realize 'a World Free from All Diseases'. This strategic collaboration opens a new chapter in the field of molecular diagnostics that aspires to a world free from all diseases and future pandemics.

In February 2020, Cepheid and Sherlock Biosciences established collaboration on New GeneXpert tests for infectious diseases and oncology leveraging CRISPR Technology. The collaboration will focus on molecular diagnostic tests for infectious diseases and oncology, beginning with a proof-of-concept project focused on the detection of coronavirus (SARS-CoV-2).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • BD (Becton, Dickinson and Company)
  • Thermo Fisher Scientific
  • Cepheid
  • QIAGEN
  • BioMerieux
  • GenMark Diagnostics
  • Luminex Corporation
  • MicroGen Diagnostics
  • Others

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Laboratory-based Tests
  • Point-of-Care Molecular Diagnostics
  • Self-testing Kits

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Viral Infections
  • Bacterial Infections
  • Parasitic Infections
  • Fungal Infections
  • Others (Zoonotic Infections, etc.)

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICES - MARKET ANALYSIS, 2019 - 2032

  • Reagents & Kits
  • Instruments
  • Software & Services

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR)
  • Real-time PCR (qPCR)
  • Reverse transcription PCR (RT-PCR)
  • Others
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Hybridization-based Assays
  • CRISPR Diagnostics
  • Others (Sanger Sequencing, Multiplex PCR, etc.)

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Point-of-Care Testing Facilities
  • Academic and Medical Institutions
  • Others

GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Diseases Molecular Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Diseases Molecular Diagnostics Market Snippet by Test Type
    • 2.1.2. Infectious Diseases Molecular Diagnostics Market Snippet by Application
    • 2.1.3. Infectious Diseases Molecular Diagnostics Market Snippet by Products & Services
    • 2.1.4. Infectious Diseases Molecular Diagnostics Market Snippet by Technology
    • 2.1.5. Infectious Diseases Molecular Diagnostics Market Snippet by End User
    • 2.1.6. Infectious Diseases Molecular Diagnostics Market Snippet by Country
    • 2.1.7. Infectious Diseases Molecular Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Diseases Molecular Diagnostics Key Market Trends

  • 3.1. Infectious Diseases Molecular Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Diseases Molecular Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Diseases Molecular Diagnostics Market Opportunities
  • 3.4. Infectious Diseases Molecular Diagnostics Market Future Trends

4. Infectious Diseases Molecular Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Diseases Molecular Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Diseases Molecular Diagnostics Market Landscape

  • 6.1. Infectious Diseases Molecular Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Diseases Molecular Diagnostics Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Laboratory-based Tests
    • 7.1.3. Point-of-Care Molecular Diagnostics
    • 7.1.4. Self-testing Kits

8. Infectious Diseases Molecular Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Viral Infections
    • 8.1.3. Bacterial Infections
    • 8.1.4. Parasitic Infections
    • 8.1.5. Fungal Infections
    • 8.1.6. Others (Zoonotic Infections, etc.)

9. Infectious Diseases Molecular Diagnostics Market - By Products & Services

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Products & Services, 2023 & 2032 (%)
    • 9.1.2. Reagents & Kits
    • 9.1.3. Instruments
    • 9.1.4. Software & Services

10. Infectious Diseases Molecular Diagnostics Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Polymerase Chain Reaction (PCR)
      • 10.1.2.1. Real-time PCR (qPCR)
      • 10.1.2.2. Reverse transcription PCR (RT-PCR)
      • 10.1.2.3. Others
    • 10.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 10.1.4. Next-Generation Sequencing (NGS)
    • 10.1.5. DNA Microarray
    • 10.1.6. Hybridization-based Assays
    • 10.1.7. CRISPR Diagnostics
    • 10.1.8. Others (Sanger Sequencing, Multiplex PCR, etc.)

11. Infectious Diseases Molecular Diagnostics Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Hospitals & Diagnostic Laboratories
    • 11.1.3. Research Institutes
    • 11.1.4. Point-of-Care Testing Facilities
    • 11.1.5. Academic and Medical Institutions
    • 11.1.6. Others

12. Infectious Diseases Molecular Diagnostics Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Infectious Diseases Molecular Diagnostics Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Products & Services, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Infectious Diseases Molecular Diagnostics Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Roche Diagnostics
    • 13.2.3. BD (Becton, Dickinson and Company)
    • 13.2.4. Thermo Fisher Scientific
    • 13.2.5. Cepheid
    • 13.2.6. QIAGEN
    • 13.2.7. BioMerieux
    • 13.2.8. GenMark Diagnostics
    • 13.2.9. Luminex Corporation
    • 13.2.10. MicroGen Diagnostics
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us